LCRClass II
Fluorescent Immunoassay, Tobramycin
21 CFR 862.3900 / Clinical Toxicology
LCR is the FDA product code for Fluorescent Immunoassay, Tobramycin, a class II device type, regulated under 21 CFR 862.3900. As of , FDA records hold 17 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- LCR
- Device name
- Fluorescent Immunoassay, Tobramycin
- Regulation
- 21 CFR 862.3900
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 17
- Ingested recalls
- 0
Clearances, product code LCR
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1980 | 2 |
| 1981 | 1 |
| 1982 | 4 |
| 1983 | 1 |
| 1984 | 1 |
| 1985 | 1 |
| 1986 | 1 |
| 1991 | 2 |
| 1995 | 1 |
| 1996 | 1 |
| 1998 | 1 |
| 2006 | 1 |
Applicants with the most clearances
Product code LCR| Applicant | Clearances |
|---|---|
| Abbott Medical | 1 |
| American Dade | 1 |
| American Diagnostic Corp. | 1 |
| Beckman Instruments, Inc. | 1 |
| Chiron Diagnostics Corp. | 1 |
| Dade Intl., Inc. | 1 |
| E.I. Dupont de Nemours & Co., Inc. | 1 |
| Electro-Nucleonics Laboratories, Inc. | 1 |
| Exmoor Plastics Limited | 1 |
| Intl. Diagnostic Technology | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
